Dr. Michael P. Menden

The mission of our research group is to develop biostatistical and machine learning frameworks applied to biomedical data, to retrieve insights in the aetiology of complex diseases and identify patient stratifications. For this, we explore deep molecular characterised biomedical datasets, environmental factors, and tailor our models depending on disease specific knowledge gained through literature and data driven analyses, thus empowering the next generation of precision medicine.

Dr. Michael P. Menden is a Junior Group Leader at the Computational Health Center, Helmholtz Munich since 2019. He is leading the Menden Lab and is Head of the DZD Computational Biology Unit. Dr. Menden became an ERC Starting Grant Laureate in 2020, and was awarded the Rising Star in Drug Discovery Award by the University of Cardiff in 2022. Previously, Dr. Menden worked as Senior Scientist in Oncology Bioinformatics, AstraZeneca, UK. He was a PhD student and postdoctoral fellow at EMBL-EBI, UK. His PhD was awarded in Computational Biology by the University of Cambridge, UK in 2016. In 2017, Dr. Menden was appointed an Honorary Lecturer position at the University of Sheffield, UK. Since 2019, Dr. Menden also became a lecturer in the Technical University of Munich (TUM) and Ludwig Maximilian University (LMU).

drug discoveryBig Dataprecision medicinedrug target identificationdrug repurposingmachine learningbiostatisticsdrug high-throughput screens